Login / Signup

Kidney disease and plasma cell dyscrasias: ambiguous cases solved by serum free light chain dimerization analysis.

Olga KukuyBatia KaplanSizilia GoldermanAlexander VolkovAdrian DuekMerav LeibaIlan Ben-ZviAvi Livneh
Published in: Clinical and experimental nephrology (2019)
FLC MDPA is a non-invasive diagnostic test useful in the management of ambiguous cases of PCD associated with kidney disease.
Keyphrases
  • single cell
  • cell therapy
  • stem cells
  • bone marrow